Clinical Trial Update: the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) [Phase 4]

View source ↗

Summary

A Phase 4 trial of gefitinib for non-small cell lung cancer is updated. The current trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 4 | Status: UNKNOWN